SCHEMBL3367907

SCHEMBL3367907

O=C(O)/C=C/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110441 1.00
SCHEMBL10601607 1.00
SCHEMBL28053415 0.96
SCHEMBL27960022 0.96
Ammonia Solution, Strong SCHEMBL9959012 0.96
Ethylene SCHEMBL9567548 0.93
Acetic Acid SCHEMBL29227417 0.89 TSHR (0.50)
SCHEMBL11257014 0.84
SCHEMBL28751101 0.82 LPAR2 (0.50)
Adamantane SCHEMBL6817495 0.82 THRB (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111206456-B Water-based non-silicon release agent, preparation method thereof and water-based non-silicon release paper 广东九佛新材料科技有限公司 2020-09-22 CN claimed
CN-111206456-A Water-based non-silicon release agent, preparation method thereof and water-based non-silicon release paper 广东九佛新材料科技有限公司 2020-05-29 CN claimed
US-9650403-B2 Platinum (II) compound, preparation method therefor, and pharmaceutical composition and application thereof SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2017-05-16 US claimed
US-20160194345-A1 PLATINUM (II) COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2016-07-07 US claimed
EP-1854857-B1 Aqueous adhesive and coating formulations AKZO NOBEL CHEMICALS INT BV (NL) 2013-04-17 EP claimed
US-8202868-B2 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO. KG (DE) 2012-06-19 US claimed
EP-1778684-B1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D&lt;sb&gt;3&lt;/sb&gt; RECEPTOR ABBOTT GMBH & CO KG (DE) 2009-12-16 EP claimed
US-20090264437-A1 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor ABBOTT GMBH & CO. KG (DE) 2009-10-22 US claimed
EP-1778684-A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D&amp;lt;sb&amp;gt;3&amp;lt;/sb&amp;gt; RECEPTOR Abbott GmbH & Co. KG (DE) 2007-05-02 EP claimed
WO-2006015842-A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-02-16 WO claimed
US-6034131-A FUGICIDE, PESTICIDE BASF AKTIENGESELLSCHAFT (DE) 2000-03-07 US claimed
EP-0503436-B1 Triazinyl substituted acrylic acid esters BAYER AG (DE) 1996-10-16 EP claimed
EP-0681579-A1 PYRAZOLYL ACRYLIC ACID DERIVATIVES, INTERMEDIATES THERETO, AND THEIR USE AS MICROBICIDES CIBA-GEIGY AG (CH) 1995-11-15 EP claimed
WO-1994017060-A1 PYRAZOLYL ACRYLIC ACID DERIVATIVES, INTERMEDIATES THERETO, AND THEIR USE AS MICROBICIDES CIBA-GEIGY AG (CH) 1994-08-04 WO claimed
EP-0388744-B1 PROCESS FOR PREPARING BETA-AMINO ACRYLIC-ACID ESTERS BAYER AG (DE) 1993-05-12 EP claimed
EP-0388744-A1 Process for preparing beta-amino acrylic-acid esters BAYER AG (DE) 1990-09-26 EP claimed
JP-2286652-A None JP disclosed
JP-59202268-A None JP disclosed
US-4483843-A ABSORPTION USING NAPHTHO QUINONE SULFONATE CONTAINING SOLUTION AND OXIDATION NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) 1984-11-20 US disclosed
JP-S59202268-A AQUEOUS COATING COMPOSITION NATOKO PAINT KK 1984-11-16 JP disclosed